Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Elekta AB    EKTA B   SE0000163628

ELEKTA AB

(EKTA B)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/01 11:25:00 am
115.475 SEK   -0.58%
11/26ELEKTA : Interim report, May-October 2020/21
AQ
11/26ELEKTA : Gustaf Salford appointed Elekta CEO by Board of Directors
AQ
11/23ELEKTA AB : half-yearly earnings release
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Elekta : Turkish hospital launches MR-guided radiotherapy program with Elekta Unity MR-Linac

07/24/2020 | 01:31am EST

Clinicians at Başkent University Ankara Hospital begin first patient treatment

ANKARA, Turkey, July 24, 2020 - On July 6, a 68-year-old man with prostate cancer became Turkey's first patient to receive radiation therapy delivered by Başkent University Ankara Hospital's Elekta Unity MR-Linac. The patient - a rectal cancer survivor - had five stereotactic body radiation therapy (SBRT) sessions, each just 35 minutes long.

According to Prof. Cem Onal, MD, Chairman of Radiation Oncology at Başkent University, Elekta Unity provided exquisite visualization of internal organs and the disease target, in addition to the ability to monitor prostate motion in real time during therapy delivery. These advantages helped better spare the patient's rectum and bladder and maximize the dose to the prostate.

"Our aim is to increase the efficacy of radiotherapy while reducing its side effects and Elekta Unity helps us achieve both of those goals," Prof. Onal says. "Moreover, this technology will drive a paradigm shift from longer treatment sessions to shorter ones and more precise radiation delivery. The ability to see the target and its motion during and between treatments means we can also modify successive treatment plans to account for changes in the cancer target."

Habib Nehme, Elekta's Executive Vice President, Turkey, India, Middle East and Africa, says: "Başkent University, under the leadership of Professor Mehmet Haberal, has always been an early adopter of the most innovative technology in cancer treatment. By acquiring and installing the first Elekta Unity MR-Linac in this region, it demonstrates once again its focus on precision radiation medicine. Unity will allow Başkent University to expand its range of techniques such as radiosurgery and SBRT, leap frogging into real-time image-guided radiotherapy." Habib adds: "With almost a quarter of a million new cancer diagnoses each year, and a shortage of linear accelerators, I am sure that more of Turkey's hospitals and cancer clinics will share Başkent University Ankara Hospital's ambitions."

Elekta Unity is a state-of-the art MR-Linac that is defining a new standard for personalized radiation therapy based on real-time high resolution anatomical and biological MRI at the point-of-care. Unity combines a Philips high-field 1.5T MRI scanner with a best-in-class 7MV linear accelerator and breakthrough online dose replanning software that are fully integrated to enable adaptive radiotherapy and real-time target monitoring.

To learn more about Elekta Unity, visit elekta.com/Unity (http://www.elekta.com/unity).

# # #

For further information, please contact:
Mattias Thorsson, Vice President, Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  
Time zone: CET: Central European Time

Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elekta on Twitter.

https://news.cision.com/elekta/r/turkish-hospital-launches-mr-guided-radiotherapy-program-with-elekta-unity-mr-linac,c3158903

https://mb.cision.com/Main/35/3158903/1283027.pdf

https://news.cision.com/elekta/i/elekta-unity-team-at-baskent-university,c2808059

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about ELEKTA AB
11/26ELEKTA : Interim report, May-October 2020/21
AQ
11/26ELEKTA : Gustaf Salford appointed Elekta CEO by Board of Directors
AQ
11/23ELEKTA AB : half-yearly earnings release
11/19ELEKTA : With Elekta Studio, Elekta brings complete image-guided brachytherapy w..
AQ
11/11ELEKTA : Invitation to the presentation of Elekta's second quarter 2020/21
PU
11/11ELEKTA : Invitation to the presentation of Elekta's second quarter 2020/21
AQ
11/06ELEKTA : newest radiotherapy system, Elekta Harmony, receives CE mark
AQ
11/04ELEKTA : Nomination Committee for the 2021 Annual General Meeting
PU
11/04ELEKTA : Nomination Committee for the 2021 Annual General Meeting
AQ
09/25ELEKTA : early out in securing MDR certificates for its linac portfolio
AQ
More news
Financials
Sales 2021 14 509 M 1 713 M 1 713 M
Net income 2021 1 410 M 166 M 166 M
Net Debt 2021 1 134 M 134 M 134 M
P/E ratio 2021 31,1x
Yield 2021 1,38%
Capitalization 44 111 M 5 193 M 5 207 M
EV / Sales 2021 3,12x
EV / Sales 2022 2,83x
Nbr of Employees 4 000
Free-Float 93,7%
Chart ELEKTA AB
Duration : Period :
Elekta AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELEKTA AB
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 110,60 SEK
Last Close Price 115,45 SEK
Spread / Highest target 42,9%
Spread / Average Target -4,20%
Spread / Lowest Target -42,0%
EPS Revisions
Managers
NameTitle
Gustaf Salford President & Chief Executive Officer
Laurent Leksell Chairman
Steven Mark Wort Chief Operating Officer
John Adebäck Chief Financial Officer & Group Treasurer
Jane M. Birgitta Göransson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ELEKTA AB-5.84%5 183
THERMO FISHER SCIENTIFIC39.56%184 288
DANAHER CORPORATION46.36%159 572
INTUITIVE SURGICAL, INC.24.11%85 351
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.85.46%62 353
EDWARDS LIFESCIENCES CORPORATION7.88%52 284